Main Article Content
Abstract
Article Details
References
- Iyer RR, Pluciennik A, Burdett V,& Modrich PL. DNA mismatch repair: functions and mechanisms. Chem Rev. 2006;106(2):302-23.
- Felipe Cavalcanti Carneiro da Silva, Mev Dominguez Valentin, Fabio de Oliveira Ferreira, Dirce Maria Carraro,& Benedito Mauro Rossi:Mismatch repair genes in Lynch syndrome.Sao Paulo Med J. 2009; 127(1):46-51.
- de la Chapelle A.:The incidence of Lynch syndrome.Fam Cancer. 2005;4(3):233-7.
- Papp J, Kovacs ME,& Olah E: Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary nonpolyposis colorectal cancer families: implications for genetic testing. World J Gastroenterol. 2007;13(19):2727-32.
- Kolodner,R.D. & G.T.Marsischky. Eukaryotic DNA mismatch repair. Curr.Opin. Genet.Dev.1999;9:89-96.
- Charles J Sheer: Principles of Tumor Supression.Cell. 2004; 116: 235-246.
- Oliveira AM, Ross JS, Fletcher JA.: Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am J Clin Pathol .2005;124:S16-28.
- Melino,G.,DeLaurenzi,V.&Vousden,K.H.:p73 and cancer: p73: Friend or foe in tumorigenesis. Nature Rev. Cancer.2002 ;2(8):605-15.
- Irwin,M.S.&Kaelin,W.G:p53 family update:p73and p63develop their own identities. Cell Growth Differ.2001;12:337-349.
- Balint,E & Vousden, K.H. Activation and activities of the p53 tumor suppressor protein .Br.J.Cancer 2002;85,1813-1823.
- King, M.C., Marks, J.H. and Mandell, J.B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science.2003;302: 643–646.
- Barbara Quaresima, Maria Concetta Faniello. Francesco Baudi, Telma Crugliano, Giovanni Cuda, Francesco Costanzo, & Salvatore Venuta: InVitro Analysis of Genomic Instability Triggered by BRCA1 Gene Missense Mutations.Hum Mutat. 2006;27(7)715.
- Crugliano T, Quaresima B, Gaspari M, Faniello MC, Romeo F, Baudi F,CudaG. Costazo F & Venuta S. Specific change in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.Int JBiochem Cell Biol. 2007;39(1):220-226.
- Rass K, &Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:162-178
- Halmbach H, Rossman E, Korn M, Schadendorf D. Drug resistance in Human melanoma. Int J Cancer 2001;93:617-22
- Joiner MC, Van Der Kogel AJ. The linear quadratic approach to fractionation and calculation of isoeffect relationships . In Stal GG, Editor. Basic Clinical Radiobiology. London; 1997. p107-21
- Seifert M, Scherer SJ, Edelmann W, Bohm M, Meineke V, Lobrich M, Tilgen W&Reichrath J. The DNA-mismatch repair enzyme hMSH2 modulates UV-Binduced cell cycle arrest and apoptosis in melanoma cells. J Invest Dermatol.2008 ;128(1):203-213.
- Stefan J et al. p53 and c-Jun functionally synergize in the regulation of theDNA repair gene hMSH2 in response to UV. J Biol Chem. 2000;275(48):37469-73.
References
Iyer RR, Pluciennik A, Burdett V,& Modrich PL. DNA mismatch repair: functions and mechanisms. Chem Rev. 2006;106(2):302-23.
Felipe Cavalcanti Carneiro da Silva, Mev Dominguez Valentin, Fabio de Oliveira Ferreira, Dirce Maria Carraro,& Benedito Mauro Rossi:Mismatch repair genes in Lynch syndrome.Sao Paulo Med J. 2009; 127(1):46-51.
de la Chapelle A.:The incidence of Lynch syndrome.Fam Cancer. 2005;4(3):233-7.
Papp J, Kovacs ME,& Olah E: Germline MLH1 and MSH2 mutational spectrum including frequent large genomic aberrations in Hungarian hereditary nonpolyposis colorectal cancer families: implications for genetic testing. World J Gastroenterol. 2007;13(19):2727-32.
Kolodner,R.D. & G.T.Marsischky. Eukaryotic DNA mismatch repair. Curr.Opin. Genet.Dev.1999;9:89-96.
Charles J Sheer: Principles of Tumor Supression.Cell. 2004; 116: 235-246.
Oliveira AM, Ross JS, Fletcher JA.: Tumor suppressor genes in breast cancer: the gatekeepers and the caretakers. Am J Clin Pathol .2005;124:S16-28.
Melino,G.,DeLaurenzi,V.&Vousden,K.H.:p73 and cancer: p73: Friend or foe in tumorigenesis. Nature Rev. Cancer.2002 ;2(8):605-15.
Irwin,M.S.&Kaelin,W.G:p53 family update:p73and p63develop their own identities. Cell Growth Differ.2001;12:337-349.
Balint,E & Vousden, K.H. Activation and activities of the p53 tumor suppressor protein .Br.J.Cancer 2002;85,1813-1823.
King, M.C., Marks, J.H. and Mandell, J.B. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science.2003;302: 643–646.
Barbara Quaresima, Maria Concetta Faniello. Francesco Baudi, Telma Crugliano, Giovanni Cuda, Francesco Costanzo, & Salvatore Venuta: InVitro Analysis of Genomic Instability Triggered by BRCA1 Gene Missense Mutations.Hum Mutat. 2006;27(7)715.
Crugliano T, Quaresima B, Gaspari M, Faniello MC, Romeo F, Baudi F,CudaG. Costazo F & Venuta S. Specific change in the proteomic pattern produced by the BRCA1-Ser1841Asn missense mutation.Int JBiochem Cell Biol. 2007;39(1):220-226.
Rass K, &Reichrath J. UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer. Adv Exp Med Biol. 2008;624:162-178
Halmbach H, Rossman E, Korn M, Schadendorf D. Drug resistance in Human melanoma. Int J Cancer 2001;93:617-22
Joiner MC, Van Der Kogel AJ. The linear quadratic approach to fractionation and calculation of isoeffect relationships . In Stal GG, Editor. Basic Clinical Radiobiology. London; 1997. p107-21
Seifert M, Scherer SJ, Edelmann W, Bohm M, Meineke V, Lobrich M, Tilgen W&Reichrath J. The DNA-mismatch repair enzyme hMSH2 modulates UV-Binduced cell cycle arrest and apoptosis in melanoma cells. J Invest Dermatol.2008 ;128(1):203-213.
Stefan J et al. p53 and c-Jun functionally synergize in the regulation of theDNA repair gene hMSH2 in response to UV. J Biol Chem. 2000;275(48):37469-73.
